H5N1: Access to Novel H5N1: Access to Novel Flu Vaccines for Those Who Contribute to Seed Stock Voo Voo Teck Chuan Assistant Professor Centre for Biomedical Ethics Yong Loo Lin School of Medicine National University of Singapore

/

Sedyaningsih et al, 2008)

/

Incidents Leading to Indonesia’s Decision to Stop Virus Sharing

Indonesia’s “No Vaccine, No Virus” Response

PIP Framework Standard Materials Transfer Agreement (SMTA) 1

PIP Framework SMTA 2 Non-GISN institutions that receives PIP biological materials from a GISRN laboratory are required to sign an SMTA 2 with WHO.